Offer - Urjas Oil for just ₹ 1 X
Combitide 25 Mcg/50 Mcg Inhaler is a prescription drug, available for use as Inhaler. Secondary and off-label uses of Combitide 25 Mcg/50 Mcg Inhaler have also been mentioned below.
Medical history of the patient along with age and gender determines the dosage of Combitide 25 Mcg/50 Mcg Inhaler. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Combitide 25 Mcg/50 Mcg Inhaler include Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Combitide 25 Mcg/50 Mcg Inhaler as well, which are listed below. Normally, these side effects of Combitide 25 Mcg/50 Mcg Inhaler are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Combitide 25 Mcg/50 Mcg Inhaler is Moderate for pregnant women and Mild for women who are breastfeeding. Further, the section on Combitide 25 Mcg/50 Mcg Inhaler related warnings talks about Combitide 25 Mcg/50 Mcg Inhaler's effects on the liver, heart and kidney.
Some other conditions that can be affected by Combitide 25 Mcg/50 Mcg Inhaler are listed in the contraindications section below.
Drug reaction of Combitide 25 Mcg/50 Mcg Inhaler with other medicines has been reported. A complete list of these interactions is given below.
In addition to the above precautions for Combitide 25 Mcg/50 Mcg Inhaler, it is important to know that it is safe while driving, and is habit-forming.
Combitide 25 Mcg/50 Mcg Inhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Combitide 25 Mcg/50 Mcg Inhaler safe for pregnant women?
Pregnant women may experience moderate side effects from Combitide. It is best to stop taking Combitide immediately and inform your doctor if you notice any discomfort.
Is the use of Combitide 25 Mcg/50 Mcg Inhaler safe during breastfeeding?
Side effects of Combitide for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Combitide 25 Mcg/50 Mcg Inhaler on the Kidneys?
Combitide is not harmful for kidneys.
What is the effect of Combitide 25 Mcg/50 Mcg Inhaler on the Liver?
You may experience side effects on your liver after taking Combitide. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Combitide 25 Mcg/50 Mcg Inhaler on the Heart?
The heart can be affected by Combitide. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Combitide 25 Mcg/50 Mcg Inhaler unless your doctor advises you to do so -
Is this Combitide 25 Mcg/50 Mcg Inhaler habit forming or addictive?
Forming a habit of Combitide 25 Mcg/50 Mcg Inhaler has not been reported.
Interaction between Food and Combitide 25 Mcg/50 Mcg Inhaler
Due to a lack of research, nothing can be said about the consequences of taking Combitide 25 Mcg/50 Mcg Inhaler together with food.
Interaction between Alcohol and Combitide 25 Mcg/50 Mcg Inhaler
It is difficult to say anything about the effect of Combitide 25 Mcg/50 Mcg Inhaler and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359